Effects of ginkgo biloba extract on cultured human retinal pigment epithelial cells under chemical hypoxia

Current Eye Research

Volumn 38, Issue 10, 2013, Pages 1072-1082

  Oh, Jong Hyun ^a   Oh, Jaeryung ^b   Togloom, Ariunaa ^b   Kim, Seong Woo ^b   Huh, Kuhl ^b  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Chemical hypoxia; Ginkgo biloba extract; Hypoxia inducible factor 1 ; Retinal pigment epithelial cell; Vascular endothelial growth factor

Indexed keywords

COBALT CHLORIDE; GINKGO BILOBA EXTRACT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIMUTAGENIC AGENTS; CELL HYPOXIA; CELLS, CULTURED; COBALT; GINKGO BILOBA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACULAR DEGENERATION; PLANT EXTRACTS; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883191569     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.804093     Document Type: Article

References (52)

1. Jager RD, Mieler WF, Miller JW. Age-related macular egeneration. N Engl J Med 2008;358:2606-2617.
2. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. Epidemiology of age-related maculopathy: a review. Eur J Epidemiol 2003;18:845-854.
3. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000;107:2224-2232.
4. Ferris III FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-1642.
5. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 2006;58:353-363.
6. Bressler SB. Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration. Ophthalmology 2009;116:S1-S7.
7. Starita C, Hussain AA, Patmore A, Marshall J. Localization of the site of major resistance to fluid transport in Bruch's membrane. Invest Ophthalmol Vis Sci 1997;38:762-767.
8. Ryan SJ, Hinton DR, Toshinori M. Choroidal neovascularization. In: Ryan SJ, editor. Retina. 4th ed. Philadelphia: Elsevier/Mosby; 2006.
9. Punglia RS, Lu M, Hsu J, Kuroki M, Tolentino MJ, Keough K, et al. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 1997; 46:1619-1626.
10. Peer J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995;72: 638-645.
11. Dor Y, Porat R, Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am J Physiol Cell Physiol 2001;280: C1367-C1374.
12. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003;22:1-29.
13. Zhang P, Wang Y, Hui Y, Hu D, Wang H, Zhou J, et al. Inhibition of VEGF expression by targeting HIF-1 alpha with small interference RNA in human RPE cells. Ophthalmologica 2007;221:411-417.
14. Forooghian F, Razavi R, Timms L. Hypoxia-inducible factor expression in human RPE cells. Br J Ophthalmol 2007;91:1406-1410.
15. Lin M, Hu Y, Chen Y, Zhou KK, Jin J, Zhu M, et al. Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization. Invest Ophthalmol Vis Sci 2012;53:6197-6206.
16. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88: 1474-1480.
17. Bracken CP, Whitelaw ML, Peet DJ. The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 2003;60:1376-1393.
18. Arjamaa O, Nikinmaa M. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp Eye Res 2006;83:473-483.
19. Hewitson KS, Schofield CJ. The HIF pathway as a therapeutic target. Drug Discov Today 2004;9:704-711.
20. Arjamaa O, Nikinmaa M, Salminen A, Kaarniranta K. Regulatory role of HIF-1alpha in the pathogenesis of agerelated macular degeneration (AMD). Ageing Res Rev 2009;8:349-358.
21. Defeudis FV. Chemical composition of Ginkgo biloba extract (EGb 761). In: Defeudis FV, editor. Ginkgo biloba extract (EGb 761): pharmacological activities and clinical applications. Paris: Elsevier; 1991.
22. Kose K, Dogan P. Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 1. Protective effect of Ginkgo biloba extract (EGb 761). J Int Med Res 1995;23:1-8.
23. Janssens D, Delaive E, Remacle J, Michiels C. Protection by bilobalide of the ischaemia-induced alterations of the mitochondrial respiratory activity. Fundam Clin Pharmacol 2000;14:193-201.
24. Sastre J, Millan A, Garcia de la Asuncion J, Pla R, Juan G, Pallardo FV, et al. A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress. Free Radic Biol Med 1998;24:298-304.
25. Cheung F, Siow YL, Chen WZ, Karmin O. Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells. Biochem Pharmacol 1999;58:1665-1673.
26. Akisu M, Kultursay N, Coker I, Huseyinov A. Plateletactivating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate 1998;74:439-444.
27. Zhu L, Wu J, Liao H, Gao J, Zhao XN, Zhang ZX. Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity. Zhongguo Yao Li Xue Bao 1997;18:344-347.
28. Kobayashi MS, Han D, Packer L. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity. Free Radic Res 2000;32: 115-124.
29. Akiba S, Kawauchi T, Oka T, Hashizume T, Sato T. Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem Mol Biol Int 1998;46:1243-1248.
30. Dutta-Roy AK, Gordon MJ, Kelly C, Hunter K, Crosbie L, Knight-Carpentar T, et al. Inhibitory effect of Ginkgo biloba extract on human platelet aggregation. Platelets 1999;10: 298-305.
31. Kim YS, Pyo MK, Park KM, Park PH, Hahn BS, Wu SJ, et al. Antiplatelet and antithrombotic effects of a combination of ticlopidine and Ginkgo biloba extract (EGb 761). Thromb Res 1998;91:33-38.
32. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997;278: 1327-1332.
33. Mouren X, Caillard P, Schwartz F. Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcPo2 determination. Angiology 1994;45:413-417.
34. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003;110:359-362; discussion 362-354.
35. Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res 2004;28:153-157.
36. Park JW, Kwon HJ, Chung WS, Kim CY, Seong GJ. Shortterm effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma. Korean J Ophthalmol 2011;25:323-328.
37. Seo JM, Yu HG, Kim YJ, Kang RM, Kim M, Park KH, et al. Protective effect of Ginkgo biloba extract (Ginexin) on a variety of damage on cultured RPE. J Korean OphthalmolSoc 2004;45:1017-1023.
38. Zhu L, Wu XM, Yang L, Du F, Qian ZM. Up-regulation of HIF-1alpha expression induced by ginkgolides in hypoxic neurons. Brain Res 2007;1166:1-8.
39. Zhao W, Wang YS, Hui YN, Zhu J, Zhang P, Li X, et al. Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cells by targeting HIF- 1alpha with short hairpin RNA-expressing plasmid DNA in human RPE cells in a coculture system. Graefes Arch Clin Exp Ophthalmol 2008;246:1413-1422.
40. Zhang P, Zhang X, Hao X, Wang Y, Hui Y, Wang H, et al. Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia. Graefes Arch Clin Exp Ophthalmol 2009; 247:633-639.
41. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113:1538-1544.
42. Kawata H, Yoshida K, Kawamoto A, Kurioka H, Takase E, Sasaki Y, et al. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 2001;88:696-704.
43. Kliffen M, Sharma HS, Mooy CM, Kerkvliet S, de Jong PT. Increased expression of angiogenic growth factors in agerelated maculopathy. Br J Ophthalmol 1997;81:154-162.
44. Bressler SB, Bressler NM, Sarks SH, Sarks JP. Age-related macular degeneration: nonneovascular early AMD, intermediate AMD, and geographic atrophy. In: Ryan SJ, editor. Retina. 4th ed. Philadelphia: Elsevier/Mosby; 2006.
45. Hibatallah J, Carduner C, Poelman MC. In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. J PharmPharmacol 1999;51:1435-1440.
46. Sloley BD, Urichuk LJ, Morley P, Durkin J, Shan JJ, Pang PK, et al. Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol 2000;52: 451-459.
47. Maerz S, Liu CH, Guo W, Zhu YZ. Anti-ischemic effects of bilobalide on neonatal rat cardiomyocytes and the involvement of the platelet-activating factor receptor. Biosci Rep 2011;31:439-447.
48. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther 1999;15:233-240.
49. Lee DJ, Ahn HB, Rho SH. The effect of Ginkgo biloba to retinal microcirculation. J Korean Ophthalmol Soc 2002;43: 1522-1527.
50. Monte M, Davel LE, de Lustig ES. Inhibition of lymphocyte- induced angiogenesis by free radical scavengers. Free Radic Biol Med 1994;17:259-266.
51. Juarez CP, Muino JC, Guglielmone H, Sambuelli R, Echenique JR, Hernandez M, et al. Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors. Eur J Ophthalmol 2000;10:51-59.
52. Koltermann A, Liebl J, Furst R, Ammer H, Vollmar AM, Zahler S. Ginkgo biloba extract EGb 761 exerts antiangiogenic effects via activation of tyrosine phosphatases. J Cell Mol Med 2009;13:2122-2130.